Caption Management »

Cue Biopharma shares owned by Caption Management

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Caption Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $65k 25k 2.64
2023-09-30 $57k 25k 2.30
2021-09-30 $396k 27k 14.56
2021-06-30 $316k 27k 11.62

More positions owned by Caption Management

Cytokinetics Com New Call Option (CYTK)
Verizon Communications Put Option (VZ)
Metropcs Communications Call Option (TMUS)
Citigroup Com New Put Option (C)
Mondelez Intl Cl A Put Option (MDLZ)
stock Call Option
Spdr Ser Tr S&p Regl Bkg Put Option (KRE)
Kenvue Call Option (KVUE)
Palo Alto Networks Put Option (PANW)
Sarepta Therapeutics Call Option (SRPT)
Spdr Ser Tr S&p Biotech Call Option (XBI)
United States Steel Corporation Call Option (X)
Tal Education Group Sponsored Ads Call Option (TAL)
Zillow Group Cl C Cap Stk Call Option (Z)
Agnico Call Option (AEM)

View all positions for Caption Management

Top funds holding Cue Biopharma

Vanguard Group
Bleichroeder
Robertson Stephens Wealth Management
Dimensional Fund Advisors
Monaco Asset Management SAM
Millennium Management
Bank of America Corporation
Sigma Planning
GSA Capital Partners
Stifel Financial
Charles Schwab Investment Management
Good Life Advisors
UBS Group
Bank of New York Mellon
HighTower Advisors

View all funds holding Cue Biopharma